ALS Biopharma

ALS Biopharma LLC is an emerging biotechnology company dedicated to discovering small molecule therapies and diagnostics for treating the debilitating neuro-orphan disease Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease). We integrate modern aspects of drug discovery, including compound library synthesis and screening. ALS Biopharma, LLC, in collaboration with top academic and industrial laboratories, is researching small molecule and bio-protein-based approaches to treat this condition.